Page 200 - 82_ex2
P. 200
The obesity pandemic… 33. Cai D, Yuan M, Frantz DF, et al. Local and systemic
insulin resistance resulting from hepatic activation of
17. Medzhitov R. Toll-like receptors and innate immunity. IKKbeta and NF-kappaB. Nat Med 2005; 11:183-90.
Nat Rev Immunol 2001; 1(2):135-45.
34. Yan SD, Schmidt AM, Anderson G. Action of
18. Gray SL, Vidal-Puig AJ. Adipose tissue expandability advanced glycation end products with their
in the maintenance of metabolic homeostasis. Nutr receptors/binding proteins. J Biol Chem 1994; 269:
Rev 2007; 65: S7-12. 9889-97.
19. Slawik M, Vidal-Puig AJ. Adipose tissue 35. Hotamisligil GS. Inflammation and metabolic
expandability and the metabolic syndrome. Genes disorders. Nature 2006; 444: 860-7.
Nutr 2007; 2(1): 41- 5.
36. Hotamisligil GS. Endoplasmic reticulum stress and
20. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation in obesity and type 2 diabetes. Novartis
inflammation, and insulin resistance. Found Symp 2007; 286: 86-94.
Gastroenterology. 2007; 132: 2169-80.
37. Wullschleger S, Loewith R, Hall MN. TOR signalling
21. Blüher M. Adipose tissue inflammation: a cause or in growth and metabolism. Cell 2006; 124: 471-84.
consequence of obesity-related insulin resistance?
Clin Sci (Lond) 2016; 130(18): 1603-14. 38. Hirosumi J, Tuncman G, Chang L, et al. A central role
for JNK in obesity and insulin resistance. Nature.
22. Randle PJ, Newsholme EA, Garland PB. Regulation 2002; 120: 333-6.
of glucose uptake by muscle. Effects of fatty acids,
ketone bodies and pyruvate, and of alloxan diabetes 39. Aguirre V, Uchida T, Yenush L, Davis R, White MF.
and starvation, on the uptake and metabolic fate of The c-Jun NH(2)-terminal kinase promotes insulin
glucose in rat heart and diaphragm muscles. Biochem resistance during association with insulin receptor
J 1964; 93: 652-65. substrate-1 and phosphorylation of Ser(307). J Biol
Chem 2000; 275: 9047-54.
23. Goodpaster BH, He J, Watkins S, et al. Skeletal
muscle lipid content and insulin resistance: evidence 40. Adams M1, Reginato MJ, Shao D, Lazar MA,
for a paradox in endurance-trained athletes. J Clin Chatterjee VK. Transcriptional activation by
Endocrinol Metab 2001; 86: 5755-61. peroxisome proliferator-activated receptor gamma is
inhibited by phosphorylation at a consensus mitogen-
24. Morino K, Petersen KF, Shulman GI. Molecular activated protein kinase site. J Biol Chem. 1997; 272:
mechanisms of insulin resistance in humans and their 5128-32.
potential links with mitochondrial dysfunction.
Diabetes 2006; 55 Suppl 2: S9-15. 41. Camp HS, Tafuri SR, Leff T. c-Jun N-terminal kinase
phosphorylates peroxisome proliferator-activated
25. Nathan C. Epidemic inflammation: pondering obesity. receptor-gamma1 and negatively regulates its
Mol Med 2008; 14: 485-92. transcriptional activity. Endocrinology 1999; 140:
392-7.
26. Hotamisligil GS, Shargill NS, Spiegelman BM.
Adipose expression of tumor necrosis factor-alpha: 42. Gregor MF, Hotamisligil GS. Thematic review series:
direct role in obesity-linked insulin resistance». Adipocyte biology. Adipocyte stress: the endoplasmic
Science 1993; 259: 87-91. reticulum and metabolic disease. J Lipid Res 2007;
48: 1905-14.
27. Weisberg SP, McCann D, Desai M, et al. Obesity is
associated with macrophage accumulation in adipose 43. Nair KS, Bigelow ML, Asmann YW, et al. Asian
tissue. J Clin Invest 2003; 112: 1796-1808. Indians have enhanced skeletal muscle mitochondrial
capacity to produce ATP in association with severe
28. Nishimura S, Manabe I, Nagasaki M, et al. In vivo insulin resistance. Diabetes 2008; 57: 1166-75.
imaging in mice reveals local cell dynamics and
inflammation in obese adipose tissue. J Clin Invest 44. Koves TR, Ussher JR, Noland RC, et al.
2008; 118: 710-21. Mitochondrial overload and incomplete fatty acid
oxidation contribute to skeletal muscle insulin
29. Blüher M. Adipose tissue inflammation: a cause or resistance. Cell Metab 2008; 7: 45-56.
consequence of obesity related insulin resistance? Clin
Sci 2016; 130 (18): 1603-14. 45. Nisoli E, Moncada S. Nitric Oxide and cell
metabolism Dysfunction in the metabolic Syndrome.
30. Hotamisligil GS. Role of endoplasmic reticulum stress In: Serrano-Ríos M, Caro FC, Carraro R, Gutierrez
and c-Jun NH2-terminal kinase pathways in Fuentes JA, Eds. The Metabolic Syndrome at the
inflammation and origin of obesity and diabetes. Beginning of The XXIst Century, chapter 18, Elsevier,
Diabetes 2005; 54 Suppl 2: S73-8. Amsterdam, 2005; pp. 306-15.
31. Wang P, Mariman E, Renes J, Keijer J. The secretory 46. Couillard C, Ruel G, Archer WR, et al. Circulating
function of adipocytesin the physiology of white levels of oxidative stress markers and endothelial
adipose tissue. J Cell Physiol 2008; 216: 3-13. adhesion molecules in men with abdominal obesity. J
Clin Endocrinol Metab 2005; 90: 6454-459.
32. Hirosumi J, Tuncman G, Chang L. A central role for
JNK in obesity and insulin resistance. Nature 2002;
120: 333-6.
@Real Academia Nacional de Farmacia. Spain 193
